Document:

Exhibit
10.2 

 

ELECTRONICALLY
SERVED

2/16/2021 6:16 PM

 

	 	Electronically
    Filed
	 	02/16/2021
    6:16 PM
	 	 
	 	 
	 	CLERK
    OF THE COURT

 

SAO

FLANGAS
LAW GROUP

KIMBERLY P. STEIN, ESQ.

Nevada Bar No. 8675

E-mail: kps@fdlawlv.com

3275 South Jones Blvd., Suite 105

Las Vegas, Nevada 89146

Telephone: (702) 307-9500

Attorneys
for Intervenor Yosef Yafe

 

DISTRICT
COURT

 

CLARK
COUNTY, NEVADA

 

	In
    the Matter of	Case
    No.: A-19-807727-P
	 	 
	POINT
    OF CARE NANO-TECHNOLOGY, INC., a Nevada Corporation.	Dept.
    No.: 14
	 	 
	 	STIPULATION
    AND ORDER APPROVING YOSEF YAFE TO INTERVENE IN THIS ACTION

 

Petitioner
INVESTMENT RESERVES SERIES POINT OF CARE NANO-TECHNOLOGY, INC., LLC (“Petitioner”) was previously appointed as Custodian
of POINT OF CARE NANO-TECHNOLOGY, INC. (“PCNT”) pursuant to an Order of this Court entered on February 11, 2020. Thereafter
pursuant to said Order, Petitioner was ordered to take several actions, which included: (1) to comply with NRS 78.18 and reinstate
to PCNT, (2) to notice a meeting of stockholders, and (3) provide a status report to the Court every one hundred twenty (120)
days. Petitioner has reinstated PCNT with the Nevada Secretary of State, and has filed a status report with the Court on June
9, 2020; however, due to the COVID pandemic Petitioner has not been able to notice or hold a meeting of stockholders and/or provide
additional reports to this Court.

 

Yosef
Yafe (“Yafe”) is also a stockholder of PCNT and desires to be a custodian for PCNT. As such, pursuant to Rule 24
of the Nevada Rules of Civil Procedure, Yafe is seeking to Intervene in this action. Yafe has represented that he is
qualified, ready and able to complete the responsibilities of the custodianship. Based upon these representations being truthful, and upon approval of the Court, Petitioner does not object to Yafe intervening in this
action.

 

Case Number: A-19-807727-P

     

     

    

As
such, Petitioner and Yafe, by and through their respective attorneys of record, hereby stipulate and agree as follows:

 

1.  
That Yosef Yafe be allowed to Intervenor in this action as a Real Party in Interest.

 

	Dated:
    February 16, 2021	 	Dated:
    : February 16, 2021
	 	 	 
	/s/Kimberly
    P. Stein	 	/s/Jay
    A. Shafer
	KIMBERLY
    P. STEIN, ESQ.	 	JAY
    A. SHAFER, ESQ.
	Nevada
    Bar No. 8675	 	Nevada
    Bar No. 9184
	FLANGAS
    LAW GROUP	 	CORY
    READE DOWS & SHAFER
	3275
    S. Jones Blvd., Suite 105	 	1333
    North Buffalo Drive, Suite 210
	Las
    Vegas, NV 89146	 	Las
    Vegas, NV 89128
	kps@fdlawlv.com	 	jshafer@crdslaw.com
	Attorneys
    for Intervenor	 	Attorneys
    for Petitioner
	Yosef
    Yafe	 	INVESTMENT
RESERVES SERIES

        POINT
OF CARE NANO-TECHNOLOGY,

        INC.,
LLC

 

ORDER

 

The
Court having reviewed the foregoing STIPULATION AND ORDER APPROVING YOSEF YAFE TO INTERVENE IN THIS ACTION in the above-entitled
matter and for good cause appearing therefor, 

 

IT
IS SO ORDERED.

 

	DATED:
    		 

  

	 	 	Dated
    this 16th day of February, 2021 
	 	 	 
	 	 	
	 	 	DISTRICT
    COURT JUDGE
	 	 	 
	Respectfully
    submitted by: 	 	99A
    984 0AE5 3028
	 	 	Adriana
    Escobar 
	FLANGAS
    LAW GROUP 	 	District
    Court Judge
	 	 	 
	/s/Kimberly
    P. Stein 	 	 
	KIMBERLY
    P. STEIN, ESQ. 	 	 
	Nevada
    Bar No. 8675 	 	 
	3275
    S. Jones Blvd., Suite 105 	 	 
	Las
    Vegas, NV 89146 	 	 
	kps@fdlawlv.com
    	 	 
	Attorneys
    for Intervenor Yosef Yafe	 	 

    -2-

     

    

From:
Jay Shafer <jshafer@crdslaw.com>

Sent: Friday, February 12, 2021 3:38 PM

To: Kimberly Stein <kps@fdlawlv.com>; Andi Hughes <ah@fdlawlv.com>

Cc: Heather Bock <hbock@crdslaw.com>

Subject: RE: In Matter Re Point of Care Nano-Technology, Inc.

 

Kim

 

You
may file the attached stipulations with my digital signature.

 

 

Jay
A. Shafer, Esq.

CORY
READE DOWS & SHAFER

1333
North Buffalo Drive, Suite 210

Las
Vegas, Nevada 89128

(702)
794-4411

jshafer@crdslaw.com

     

     

    

CSERV

 

DISTRICT
COURT

CLARK
COUNTY, NEVADA

 

	In
    the Matter of the Petition of	CASE
    NO: A-19-807727-P
	 	 
	Investment
    Reserves Series Point of Care nano-Technology, Inc. LLC	DEPT.
    NO. Department 14

 

AUTOMATED
CERTIFICATE OF SERVICE

 

This
automated certificate of service was generated by the Eighth Judicial District Court. The foregoing Stipulation and Order was
served via the court’s electronic eFile system to all recipients registered for e-Service on the above entitled case as
listed below:

 

Service
Date: 2/16/2021

 

	Jay
    Shafer	JShafer@premierlegalgroup.com
	 	 
	Leslie
    Reynolds	lmr@fdlawlv.com
	 	 
	Kimberly
    Stein	kps@fdlawlv.com
	 	 
	Andi
    Hughes	ah@fdlawlv.comExhibit 10.3 

 

SEPARATION
AND RELEASE OF CLAIMS AGREEMENT

 

This
Separation and Release of Claims Agreement (“Agreement”) is entered into by and between Point of Care Nanotechnologies,
Inc., a Nevada corporation (the “Company”), on behalf of itself, subsidiaries, and other corporate affiliates and
each of their respective present and former directors, officers, directors, owners, shareholders, and agents, individually and in their
official capacities (collectively referred to as the “Company Group”), and Dr. Raouf Guirguis (the “Director”),
residing in STATE (the Company and the Director are collectively referred to as the “Parties” and each as a “Party”)
as of April 15, 2021 (the “Execution Date”).

 

WHEREAS,
the Director has resigned from the Company’s Board of Directors and all other positions, effective as of April 15, 2021. (the “Separation
Date”).

 

WHEREAS,
after the Separation Date, the Director will not represent himself as being a director, employee, officer, attorney, agent, or representative
of the Company Group for any purpose.

 

WHEREAS,
except as otherwise set forth in this Agreement, the Separation Date was the termination date for the Director for all purposes, meaning
the Director is not entitled to any further compensation, monies, or other benefits from the Company Group, including coverage under
any benefit plans or programs sponsored by the Company Group, as of the Separation Date.

 

NOW,
THEREFORE, in consideration of the following, the Parties hereby agree to the following. 

 

1.            Return
of Property. The Director warrants and represents
that he will return all Company Group property in the Director’s possession.

 

2.            Director
Representations. The Director specifically represents, warrants, and confirms that the Director:

 

(a)           has
not filed any claims, complaints, or actions of any kind against the Company Group with any court of law, or local, state, or federal
government or agency;

 

(b)           has
not engaged in and is not aware of any unlawful conduct relating to the business of the Company Group.

     

     

    

3.           Release.

 

(a)           Director’s
General Release and Waiver of Claims

 

In
exchange for the consideration provided in this Agreement, the Director and the Director’s heirs, executors, representatives, administrators,
agents, and assigns (collectively, the “Releasors”) irrevocably and unconditionally fully and forever waive, release,
and discharge the Company Group, including each member of the Company Group’s parents, subsidiaries, affiliates, predecessors,
successors, and assigns, and all of their respective officers, directors, directors and shareholders, in their corporate and individual
capacities (collectively, the “Released Parties”), from any and all claims, demands, actions, causes of actions, judgments,
rights, fees, damages, debts, obligations, liabilities, and expenses (inclusive of attorneys’ fees) of any kind whatsoever, whether
known or unknown (collectively, “Claims”), that Director may have or has ever had against the Released Parties, or
any of them, by reason of any actual or alleged act, omission, transaction, practice, conduct, occurrence, or other matter from the beginning
of time up to and including the date of the Director’s execution of this Agreement, including, but not limited to:

 

(i)         any
and all claims under federal, state, local, or foreign law (statutory, regulatory, or otherwise) that may be legally waived and released;

 

(ii)        any
and all claims for compensation of any type whatsoever that may be legally waived and released;

 

(iii)       any
and all claims arising under tort, contract, and quasi-contract law; and

 

(iv)       any
and all claims for monetary or equitable relief.

 

However,
this general release and waiver of claims excludes, and the Director does not waive, release, or discharge: (A) claims that cannot be
waived by law and (B) any rights the Director has under the Company’s Director and Officer Liability Insurance Policy(ies).

 

(b)           Company
Group Release of Director

 

In
exchange for the Releasors’ waiver and release of claims against the Released Parties, and non-revocation of any portion of that
release, the Company Group irrevocably and unconditionally fully and forever waive, release, and discharge the Director, from any and
all Claims that Company Group may have or has ever had against the Director, by reason of any actual or alleged act, omission, transaction,
practice, conduct, occurrence, or other matter from the beginning of time up to and including the date of the Director’s execution
of this Agreement, with the exception of claims arising out of or attributable to: (i) events, acts, or omissions taking place after
the Parties’ execution of the Agreement; (ii) the Director’s breach of any terms and conditions of the Agreement; and (iii)
the Director’s criminal activities or intentional misconduct occurring during the Director’s employment with the Company
Group.

 

4.           Knowing
and Voluntary Acknowledgment. The Director specifically agrees and acknowledges that:

 

(a)           the
Director has read this Agreement in its entirety and understands all of its terms;

 

(b)           by
this Agreement, the Director has been advised to consult with an attorney before executing this Agreement;

    2

     

    

(c)            the
Director knowingly, freely, and voluntarily assents to all of this Agreement’s terms and conditions including, without limitation,
the waiver, release, and covenants contained in it;

 

(d)           the
Director is signing this Agreement, including the waiver and release, in exchange for good and valuable consideration in addition to
anything of value to which the Director is otherwise entitled;

 

(e)           the
Director is not waiving or releasing rights or claims that may arise after the Director signs this Agreement; and

 

(f)           the
Director understands that the waiver and release in this Agreement is being requested in connection with the Director’s separation
from the Company Group.

 

5.       Cooperation.
The parties agree that certain matters in which the Director has been involved during the Director’s employment may need the Director’s
cooperation with the Company in the future. Accordingly, for a period of six months after the Separation Date, to the extent reasonably
requested by the Company, the Director shall cooperate with the Company in connection with matters arising out of the Director’s
service to the Company; provided that the Company shall make reasonable efforts to minimize disruption of the Director’s other
activities.

 

6.       Governing
Law, Jurisdiction, and Venue. This Agreement
and all matters arising out of or relating to this Agreement, whether sounding contract, tort, or statute, for all purposes shall be
governed by and construed in accordance with the laws of Nevada (including its statutes of limitations) without regard to any conflicts
of laws principles that would require the laws of any other jurisdiction to apply.

 

7.       Entire
Agreement. Unless specifically provided herein, this Agreement contains all of the understandings and representations between
Company Group and Director relating to the subject matter hereof and supersedes all prior and contemporaneous understandings, discussions,
agreements, representations, and warranties, both written and oral, regarding such subject matter.

 

8.       Modification
and Waiver. No provision of this Agreement
may be amended or modified unless the amendment or modification is agreed to in writing and signed by the Director and by the Chief Executive
Officer of the Company. No waiver by either Party of any breach by the other party of any condition or provision of this Agreement to
be performed by the other party shall be deemed a waiver of any similar or dissimilar provision or condition at the same or any prior
or subsequent time, nor shall the failure of or delay by any Party in exercising any right, power, or privilege under this Agreement
operate as a waiver thereof to preclude any other or further exercise thereof or the exercise of any other such right, power, or privilege.

 

9.       Severability.
Should any provision of this Agreement be held by a court of competent jurisdiction to be enforceable only if modified, or if any portion
of this Agreement shall be held to be unenforceable and thus stricken, such holding shall not affect the validity of the remainder of
this Agreement, the balance of which shall continue to be binding on the Parties with any such modification to become a part hereof and
treated as though originally set forth in this Agreement.

    3

     

    

10.       Captions.
Captions and headings of the sections and paragraphs of this Agreement are intended solely for convenience and no provision of this Agreement
is to be construed by reference to the caption or heading of any section or paragraph.

 

11.       Counterparts.
The Parties may execute this Agreement in counterparts, each of which shall be deemed an original, and all of which taken together shall
constitute one and the same instrument. Delivery of an executed counterpart’s signature page of this Agreement by facsimile, email
in portable document format (.pdf), or by any other electronic means intended to preserve the original graphic and pictorial appearance
of a document has the same effect as delivery of an executed original of this Agreement.

 

12.       No
Admission of Liability. Nothing in this Agreement shall be construed as an admission by the Director or the Company Group
of any wrongdoing, liability, or noncompliance with any federal, state, city, or local rule, ordinance, statute, common law, or other
legal obligation.

 

13.       Notices.
All notices under this Agreement must be given in writing by personal delivery/regular mail/receipted email at the addresses indicated
in this Agreement or any other address designated in writing by either Party.

 

14.       Acknowledgment
of Full Understanding. THE DIRECTOR ACKNOWLEDGES
AND AGREES THAT THE DIRECTOR HAS FULLY READ, UNDERSTANDS, AND VOLUNTARILY ENTERS INTO THIS AGREEMENT. THE DIRECTOR ACKNOWLEDGES AND AGREES
THAT THE DIRECTOR HAS HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF THE DIRECTOR’S CHOICE BEFORE SIGNING
THIS AGREEMENT. THE DIRECTOR FURTHER ACKNOWLEDGES THAT THE DIRECTOR’S SIGNATURE BELOW IS AN AGREEMENT TO RELEASE COMPANY GROUP
FROM ANY AND ALL CLAIMS THAT CAN BE RELEASED AS A MATTER OF LAW.

 

IN
WITNESS WHEREOF, the Parties have executed this Agreement as of the Execution Date above.

 

	 	POINT
    OF CARE NANOTECHNOLOGIES, INC. 
	 	 
	 	By:	/s/ Aymen El Salhy	   
	 	

    Name:
Aymen El Salhy 

    Title:
    Director

    

 

	DIRECTOR

     
	 
	Signature: 
	/s/ Dr. Raouf Guirguis 
	 
	Print
Name: Dr. Raouf Guirguis 	 

    4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]